Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Dalack

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Research|October 23, 1998
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disordersA Diwan, M Castine, C S Pomerleau, et al.
Journal of Clinical Pharmacy and Therapeutics|February 27, 2016
Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based interventionJ Lee, G W Dalack, M I Casher, et al.
International Journal of Culture and Mental Health|August 11, 2015
Measuring depression and stigma towards depression and mental health treatment among adolescents in an Arab-American communityR M Jaber, M Farroukh, M Ismail, et al.
The American Journal of Psychiatry|April 1, 1991
Cardiovascular effects of bupropion in depressed patients with heart diseaseS P Roose, G W Dalack, A H Glassman, et al.
The American Journal of Psychiatry|February 16, 1999
Striatal dopaminergic abnormalities in human cocaine usersK Y Little, L Zhang, T Desmond, et al.
The Journal of Clinical Psychiatry|August 1, 1991
Is doxepin a safer tricyclic for the heart?S P Roose, G W Dalack, A H Glassman, et al.
Biological Psychiatry|March 1, 1997
Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onsetD Malaspina, G Bruder, G W Dalack, et al.
Clinical Pharmacology and Therapeutics|December 1, 1993
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokersA H Glassman, L S Covey, G W Dalack, et al.
Archives of General Psychiatry|September 15, 1998
Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem studyK Y Little, D P McLaughlin, L Zhang, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Schizophrenia Research|October 23, 1998
Differential prevalence of cigarette smoking in patients with schizophrenic vs mood disordersA Diwan, M Castine, C S Pomerleau, et al.
Journal of Clinical Pharmacy and Therapeutics|February 27, 2016
Persistence of metabolic monitoring for psychiatry inpatients treated with second-generation antipsychotics utilizing a computer-based interventionJ Lee, G W Dalack, M I Casher, et al.
International Journal of Culture and Mental Health|August 11, 2015
Measuring depression and stigma towards depression and mental health treatment among adolescents in an Arab-American communityR M Jaber, M Farroukh, M Ismail, et al.
The American Journal of Psychiatry|April 1, 1991
Cardiovascular effects of bupropion in depressed patients with heart diseaseS P Roose, G W Dalack, A H Glassman, et al.
The American Journal of Psychiatry|February 16, 1999
Striatal dopaminergic abnormalities in human cocaine usersK Y Little, L Zhang, T Desmond, et al.
The Journal of Clinical Psychiatry|August 1, 1991
Is doxepin a safer tricyclic for the heart?S P Roose, G W Dalack, A H Glassman, et al.
Biological Psychiatry|March 1, 1997
Diminished cardiac vagal tone in schizophrenia: associations to brain laterality and age of onsetD Malaspina, G Bruder, G W Dalack, et al.
Clinical Pharmacology and Therapeutics|December 1, 1993
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokersA H Glassman, L S Covey, G W Dalack, et al.
Archives of General Psychiatry|September 15, 1998
Brain dopamine transporter messenger RNA and binding sites in cocaine users: a postmortem studyK Y Little, D P McLaughlin, L Zhang, et al.
The American Journal of Psychiatry|February 17, 1998
Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levelsK Y Little, D P McLaughlin, L Zhang, et al.
Pageof 3